Urinary cytology as a test in mass screening

Area of Science:

• Urology
• Oncology
• Cytopathology

Background:

• Early detection of urinary tract cancers improves patient outcomes.
• Cytologic screening offers a non-invasive method for identifying malignancy.
• Toluidine blue staining provides a rapid and simple method for cytologic analysis.

Purpose of the Study:

• To evaluate a rapid, simple cytologic screening system for urinary tract cancer using toluidine blue staining.
• To assess the feasibility of screening a general hospital population for urinary tract cancer via routine urinalysis specimens.

Main Methods:

• A total of 16,062 fresh urine sediments from non-urologic patients were randomly selected.
• Specimens were stained with toluidine blue for cytologic examination.
• Histologic confirmation was performed for detected cases.

Main Results:

• Three cases of histologically proven bladder cancer were detected.
• The detection rate for bladder cancer was one in 5,000 individuals screened.
• The screening system demonstrated effectiveness in identifying malignancy.

Conclusions:

• The toluidine blue cytologic screening system is a useful tool for early detection of urinary tract malignancy.
• Combining this screening technique with clinical urinalysis and cytology enhances diagnostic capabilities.
• The method is practical for widespread application in hospital settings.